Linearization correction of /sup 99m/Tc-labeled hexamethyl-propylene amine oxime (HM-PAO) image in terms of regional CBF distribution: comparison to C VO2 inhalation steady-state method measured by positron emission tomography
The radioisotope distribution following intravenous injection of 99mTc-labeled hexamethylpropyleneamine oxime (HM-PAO) in the brain was measured by single photon emission computed tomography (SPECT) and corrected for the nonlinearity caused by differences in net extraction. The linearization correction was based on a three compartment model, and it required a region of reference to normalize the SPECT image in terms of regional cerebral blood flow distribution. Two different regions of reference, the cerebellum and the whole brain, were tested. The uncorrected and corrected HM-PAO images were compared with cerebral blood flow (CBF) image measured by the C VO2 inhalation steady state method and positron emission tomography (PET). The relationship between uncorrected HM-PAO and PET-CBF showed a correlation coefficient of 0.85 but tended to saturate at high CBF values, whereas it was improved to 0.93 after the linearization correction. The whole-brain normalization worked just as well as normalization using the cerebellum. This study constitutes a validation of the linearization correction and it suggests that after linearization the HM-PAO image may be scaled to absolute CBF by employing a global hemispheric CBF value as measured by the nontomographic TTXe clearance method.
- Research Organization:
- Research Institute for Brain and Blood Vessels-Akita (Japan)
- OSTI ID:
- 6610927
- Journal Information:
- J. Cereb. Blood Flow Metab.; (United States), Vol. 8:6
- Country of Publication:
- United States
- Language:
- English
Similar Records
Tomographic studies of rCBF with (/sup 99m/Tc)-HM-PAO SPECT in patients with brain tumors: comparison with C VO2 continuous inhalation technique and PET
Filling out phenomenon with technetium-99m HM-PAO brain SPECT at the site of mild cerebral ischemia
Related Subjects
BRAIN
BLOOD FLOW
RADIOPHARMACEUTICALS
UPTAKE
ALGORITHMS
CARBON DIOXIDE
COMPARATIVE EVALUATIONS
INTRAVENOUS INJECTION
ISOMERIC NUCLEI
ORGANOMETALLIC COMPOUNDS
OXIMES
OXYGEN 15
POSITRON COMPUTED TOMOGRAPHY
TECHNETIUM 99
XENON 133
AMINES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
CARBON COMPOUNDS
CARBON OXIDES
CENTRAL NERVOUS SYSTEM
CHALCOGENIDES
COMPUTERIZED TOMOGRAPHY
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DRUGS
EMISSION COMPUTED TOMOGRAPHY
EVEN-ODD NUCLEI
HOURS LIVING RADIOISOTOPES
HYDROXY COMPOUNDS
INJECTION
INTAKE
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
MATHEMATICAL LOGIC
MINUTES LIVING RADIOISOTOPES
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANS
OXIDES
OXYGEN COMPOUNDS
OXYGEN ISOTOPES
RADIOISOTOPES
TECHNETIUM ISOTOPES
TOMOGRAPHY
XENON ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics